[HTML][HTML] Cost-utility analysis of dabigatran and warfarin for stroke prevention among patients with nonvalvular atrial fibrillation in India

R Aghoram, SM Kumar, SR Rajasulochana… - Value in Health …, 2022 - Elsevier
Objectives Dabigatran has a better safety profile and requires less monitoring, but is costlier
than warfarin. This study evaluated the cost-utility of dabigatran relative to warfarin for …

Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India.

R Aghoram, SM Kumar, SR Rajasulochana… - Value in Health …, 2022 - europepmc.org
Objectives Dabigatran has a better safety profile and requires less monitoring, but is costlier
than warfarin. This study evaluated the cost-utility of dabigatran relative to warfarin for …

Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India

R Aghoram, SM Kumar… - Value in health …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives Dabigatran has a better safety profile and requires less monitoring, but is costlier
than warfarin. This study evaluated the cost-utility of dabigatran relative to warfarin for …

[HTML][HTML] Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India

R Aghoram, SM Kumar… - Value in Health …, 2022 - valuehealthregionalissues.com
Objectives Dabigatran has a better safety profile and requires less monitoring, but is costlier
than warfarin. This study evaluated the cost-utility of dabigatran relative to warfarin for …